Tomer Levy - 02 Oct 2024 Form 4 Insider Report for Augmedix, Inc.

Role: SVP, ENGINEERING
Signature: /s/ Todd Holvick, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 02 Oct 2024
Net transactions value: $0
Form type: 4
Filing time: 04 Oct 2024, 13:14:33 UTC
Previous filing: 27 Feb 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AUGX	Restricted Stock Units	Disposed to Issuer	$0	-105,000	-100%	$0.000000	0	02 Oct 2024	Common Stock	105,000		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Tomer Levy is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
F2	Pursuant to the Merger Agreement, at the Effective Time, the restricted stock units were replaced with a cash incentive program, which preserves the compensation elements and vesting terms of the restricted stock units.